NO161204C - Fremgangsm te for fremstilling av en insulinopploesn - Google Patents

Fremgangsm te for fremstilling av en insulinopploesn

Info

Publication number
NO161204C
NO161204C NO830385A NO830385A NO161204C NO 161204 C NO161204 C NO 161204C NO 830385 A NO830385 A NO 830385A NO 830385 A NO830385 A NO 830385A NO 161204 C NO161204 C NO 161204C
Authority
NO
Norway
Prior art keywords
preparing
procedure
insulin solution
insulin
solution
Prior art date
Application number
NO830385A
Other languages
English (en)
Norwegian (no)
Other versions
NO161204B (no
NO830385L (no
Inventor
Jens Joergen Vejlgaard Brange
Svend Havelund
Original Assignee
Novo Industri As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Industri As filed Critical Novo Industri As
Publication of NO830385L publication Critical patent/NO830385L/no
Publication of NO161204B publication Critical patent/NO161204B/no
Publication of NO161204C publication Critical patent/NO161204C/no

Links

Classifications

    • H—ELECTRICITY
    • H05—ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
    • H05K—PRINTED CIRCUITS; CASINGS OR CONSTRUCTIONAL DETAILS OF ELECTRIC APPARATUS; MANUFACTURE OF ASSEMBLAGES OF ELECTRICAL COMPONENTS
    • H05K13/00—Apparatus or processes specially adapted for manufacturing or adjusting assemblages of electric components
    • H05K13/06—Wiring by machine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Manufacturing & Machinery (AREA)
  • Microelectronics & Electronic Packaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
NO830385A 1982-02-05 1983-02-04 Fremgangsm te for fremstilling av en insulinopploesn NO161204C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK49182 1982-02-05

Publications (3)

Publication Number Publication Date
NO830385L NO830385L (no) 1983-08-08
NO161204B NO161204B (no) 1989-04-10
NO161204C true NO161204C (no) 1989-07-19

Family

ID=8094159

Family Applications (1)

Application Number Title Priority Date Filing Date
NO830385A NO161204C (no) 1982-02-05 1983-02-04 Fremgangsm te for fremstilling av en insulinopploesn

Country Status (22)

Country Link
US (1) US4476118A (cs)
JP (1) JPS58192818A (cs)
AT (1) AT382780B (cs)
AU (1) AU549981B2 (cs)
BE (1) BE895832A (cs)
CA (1) CA1203476A (cs)
CH (1) CH657530A5 (cs)
DE (1) DE3303860A1 (cs)
ES (1) ES8500060A1 (cs)
FI (1) FI78616C (cs)
FR (1) FR2521009B1 (cs)
GB (1) GB2114573B (cs)
GR (1) GR77388B (cs)
IE (1) IE54548B1 (cs)
IT (1) IT1178455B (cs)
LU (1) LU84632A1 (cs)
NL (1) NL187269C (cs)
NO (1) NO161204C (cs)
NZ (1) NZ203189A (cs)
PT (1) PT76195B (cs)
SE (1) SE460948B (cs)
ZA (1) ZA83742B (cs)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3576120D1 (de) * 1984-06-09 1990-04-05 Hoechst Ag Insulinzubereitungen, verfahren zu deren herstellung und deren verwendung.
JP2520262B2 (ja) * 1987-08-21 1996-07-31 春幸 川原 パツチテスト材料
US4789660A (en) * 1987-09-10 1988-12-06 American Home Products Corporation Insulin administration using methyl and propyl paraben
US5130298A (en) * 1989-05-16 1992-07-14 Ethicon, Inc. Stabilized compositions containing epidermal growth factor
US5534488A (en) * 1993-08-13 1996-07-09 Eli Lilly And Company Insulin formulation
US5474978A (en) * 1994-06-16 1995-12-12 Eli Lilly And Company Insulin analog formulations
AR002976A1 (es) * 1995-03-31 1998-05-27 Lilly Co Eli Formulaciones farmaceuticas parenterales de efecto prolongado de insulina; cristales de dichos analogos aplicables en dichas formulaciones yprocedimiento de las formulaciones mencionadas
JP4307550B2 (ja) * 1995-11-13 2009-08-05 メドトロニック ミニメッド、 インコーポレイティド 単量体状タンパク質の送達のための方法及び組成物
AU2260097A (en) * 1996-03-12 1997-10-01 Life Technologies, Inc. Hematopoietic cell culture nutrient supplement
DK0821006T3 (da) * 1996-07-26 2004-08-16 Aventis Pharma Gmbh Insulinderivater med öget zinkbinding
PE79099A1 (es) * 1997-06-13 1999-08-24 Lilly Co Eli Formulaciones de insulina estables
SI0884053T1 (en) * 1997-06-13 2003-02-28 Eli Lilly And Company Stable insulin formulations
WO1999024015A1 (en) * 1997-11-12 1999-05-20 Alza Corporation Buffered drug formulations for transdermal electrotransport delivery
DE19825447A1 (de) 1998-06-06 1999-12-09 Hoechst Marion Roussel De Gmbh Neue Insulinanaloga mit erhöhter Zinkbildung
DE69920767T2 (de) * 1998-10-16 2006-02-02 Novo Nordisk A/S Stabile konzentrierte Insulin Präparationen zur pulmonaren Verabreichung
DE19930676B4 (de) * 1999-07-02 2006-01-19 Sanofi-Aventis Deutschland Gmbh Verfahren zur Stabilisierung von Insulin, Insulinderivaten und/oder deren Vorläufer in komplexen Mischungen bei deren Lagerung in wäßrigen Lösungsmitteln
EP1265630B1 (en) * 2000-03-24 2006-06-07 Genentech, Inc. Use of insulin for the treatment of cartilagenous disorders
JP4147234B2 (ja) * 2004-09-27 2008-09-10 キヤノン株式会社 吐出用液体、吐出方法、カートリッジ及び吐出装置
ATE496064T1 (de) 2002-05-07 2011-02-15 Novo Nordisk As Lösliche formulierungen, die monomeres insulin und acyliertes insulin enthalten
JP2006516966A (ja) * 2002-12-20 2006-07-13 ノボ　ノルディスク　アクティーゼルスカブ 安定化されたインスリン組成物
US20050065066A1 (en) * 2002-12-20 2005-03-24 Kaarsholm Niels Christian Stabilised insulin compositions
WO2004096266A1 (en) * 2003-05-02 2004-11-11 Novo Nordisk A/S Improved physical stability of insulin formulations
JP4463814B2 (ja) * 2003-08-05 2010-05-19 ノボ ノルディスク アクティーゼルスカブ 新規のインスリン誘導体
PL2626368T3 (pl) 2004-07-19 2017-06-30 Biocon Limited Koniugaty insulina-oligomer, ich formulacje i zastosowania
ATE519780T1 (de) * 2005-12-28 2011-08-15 Novo Nordisk As Ein acyliertes insulin und zink enthaltende zusammensetzungen und verfahren zur herstellung dieser zusammensetzungen
US20090136538A1 (en) * 2006-05-22 2009-05-28 Jan Jezek Stable vaccine formulation
GB0700523D0 (en) * 2007-01-11 2007-02-21 Insense Ltd The Stabilisation Of Proteins
PL2134351T3 (pl) 2007-03-13 2017-10-31 Jds Therapeutics Llc Sposoby i kompozycje do przedłużonego uwalniania chromu
US9034818B2 (en) * 2007-06-13 2015-05-19 Novo Nordisk A/S Pharmaceutical formulations comprising an insulin derivative
WO2009002867A2 (en) 2007-06-26 2008-12-31 Nutrition 21, Inc. Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement
MX2010005245A (es) 2007-11-16 2010-06-01 Novo Nordisk As Composiciones farmaceuticas que comprenden peptidos glp-1 o exendin-4 y un peptido de insulina basal.
EP2341940A1 (en) * 2008-07-16 2011-07-13 Arecor Limited The stabilisation of proteins
EP2328607A1 (en) * 2008-07-16 2011-06-08 Arecor Limited Stable formulation of a therapeutic protein
EP2352513B1 (en) * 2008-10-30 2016-09-14 Novo Nordisk A/S Treating diabetes melitus using insulin injections with less than daily injection frequency
US9060927B2 (en) 2009-03-03 2015-06-23 Biodel Inc. Insulin formulations for rapid uptake
RU2013123515A (ru) 2010-10-27 2014-12-10 Ново Нордиск А/С Лечение сахарного диабета с помощью инъекций инсулина, вводимых с различными интервалами
JP6152346B2 (ja) 2011-03-01 2017-06-21 ジェーディーエス セラピューティックス、エルエルシーＪＤＳ Ｔｈｅｒａｐｅｕｔｉｃｓ，ＬＬＣ 糖尿病、低血糖、および関連障害の治療および予防のためのインスリンとクロムの組成物
EA034393B1 (ru) 2012-11-13 2020-02-03 Адосиа Состав инсулина быстрого действия, содержащий замещенное анионное соединение
CA2889165A1 (en) * 2012-12-19 2014-06-26 Wockhardt Limited A stable aqueous composition comprising human insulin or an analogue or derivative thereof
CN104870469A (zh) 2012-12-26 2015-08-26 沃克哈特有限公司 药物组合物
TWI641381B (zh) * 2013-02-04 2018-11-21 法商賽諾菲公司 胰島素類似物及／或胰島素衍生物之穩定化醫藥調配物
WO2014177623A1 (en) 2013-04-30 2014-11-06 Novo Nordisk A/S Novel administration regime
US9822158B2 (en) * 2013-12-04 2017-11-21 Merck Sharp & Dohme Corp. Method for preparing crystalline insulin
TW201630622A (zh) 2014-12-16 2016-09-01 美國禮來大藥廠 速效胰島素組合物
JO3749B1 (ar) 2015-08-27 2021-01-31 Lilly Co Eli تركيبات إنسولين سريعة المفعول
MX2018009748A (es) 2016-02-11 2019-02-07 Nutrition 21 Llc Composiciones que contienen cromo para mejorar la salud y el estado físico.
ES2954180T3 (es) * 2016-09-29 2023-11-20 Arecor Ltd Formulación farmacéutica que comprende un compuesto de insulina
EA201992351A1 (ru) 2017-06-01 2020-03-26 Эли Лилли Энд Компани Быстродействующие композиции инсулина
US10335464B1 (en) 2018-06-26 2019-07-02 Novo Nordisk A/S Device for titrating basal insulin
US12343383B2 (en) 2019-07-12 2025-07-01 Novo Nordisk A/S High concentration insulin formulation

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2882202A (en) * 1950-04-05 1959-04-14 Novo Terapeutisk Labor As Insulin crystal preparations and methods of producing them
US2787575A (en) * 1950-11-22 1957-04-02 Organon Zinc-glycine-insulin composition and production thereof
US2882203A (en) * 1951-06-26 1959-04-14 Novo Terapeutisk Labor As Injectable insulin preparation with protracted effect
DE1044360B (de) * 1953-08-19 1958-11-20 Roskilde Medical Company Ltd R Verfahren zur Herstellung von Zinkinsulin mit erhoehtem Zinkgehalt
DE956098C (de) * 1954-02-18 1957-01-10 Dr Dr Guenther Weitzel Verfahren zur Herstellung zinkreicher Insulin-Komplexverbindungen
US3058885A (en) * 1957-06-08 1962-10-16 Novo Terapeutisk Labor As Process for treatment of insulin crystals and for production of insulin preparationstherefrom
US3014842A (en) * 1957-08-10 1961-12-26 Novo Terapeutish Lab A S Injectable bovine insulin crystal suspensions and process of producing same
US3091573A (en) * 1958-05-12 1963-05-28 Novo Terapeutisk Labor As Quick acting insulin preparation
FR1263220A (fr) * 1958-08-01 1961-06-09 Novo Terapeutisk Labor As Procédé de production d'une préparation d'insuline à action rapide
DK116527B (da) * 1967-03-01 1970-01-19 Nordisk Insulinlab Fremgangsmåde til fremstilling af en hurtigtvirkende, holdbar, neutral opløsning af rent krystallinsk okseinsulin eller okseinsulin, der ved tilsætning af Zn er krystalliserbart i vand, eller blandinger af okseinsulin og insulin af anden oprindelse.
GB1285023A (en) * 1968-08-09 1972-08-09 Novo Terapeutisk Labor As Improvements in or relating to injectable insulin preparations
US3657425A (en) * 1969-03-12 1972-04-18 Burroughs Wellcome Co Beef insulin preparations
DE2459515C3 (de) * 1974-12-17 1982-02-11 Hoechst Ag, 6000 Frankfurt Arzneimittelzubereitungen mit antidiabetischer Wirkung
DE3064888D1 (en) * 1979-04-30 1983-10-27 Hoechst Ag Aqueous solutions of proteins stable against denaturization, process for their manufacture, and their utilization
DK80781A (da) * 1980-02-29 1981-08-30 Hospital For Sick Children Oploesninger af polypeptider
WO1983003054A1 (en) * 1982-03-03 1983-09-15 Johansen, Kristian, Betton A proces for producing an insulin preparation

Also Published As

Publication number Publication date
ZA83742B (en) 1983-11-30
CA1203476A (en) 1986-04-22
NL187269C (nl) 1991-08-01
FI78616C (fi) 1989-09-11
IE54548B1 (en) 1989-11-08
ES519533A0 (es) 1984-10-16
FR2521009B1 (fr) 1987-07-17
IT8319420A0 (it) 1983-02-04
ES8500060A1 (es) 1984-10-16
IE830220L (en) 1983-08-05
NO161204B (no) 1989-04-10
SE8300598L (sv) 1983-08-06
BE895832A (fr) 1983-08-04
SE8300598D0 (sv) 1983-02-04
GB2114573A (en) 1983-08-24
GR77388B (cs) 1984-09-11
ATA38983A (de) 1986-09-15
US4476118A (en) 1984-10-09
IT1178455B (it) 1987-09-09
CH657530A5 (de) 1986-09-15
GB2114573B (en) 1985-05-01
NL8300440A (nl) 1983-09-01
PT76195A (en) 1983-03-01
FI78616B (fi) 1989-05-31
NL187269B (nl) 1991-03-01
AU1113683A (en) 1983-08-11
DE3303860C2 (cs) 1989-12-28
FI830375L (fi) 1983-08-06
DE3303860A1 (de) 1983-08-18
SE460948B (sv) 1989-12-11
LU84632A1 (fr) 1983-09-08
FR2521009A1 (fr) 1983-08-12
NO830385L (no) 1983-08-08
FI830375A0 (fi) 1983-02-03
AT382780B (de) 1987-04-10
JPH0367056B2 (cs) 1991-10-21
PT76195B (en) 1986-01-27
JPS58192818A (ja) 1983-11-10
AU549981B2 (en) 1986-02-20
GB8303133D0 (en) 1983-03-09
NZ203189A (en) 1985-07-31

Similar Documents

Publication Publication Date Title
NO161204C (no) Fremgangsm te for fremstilling av en insulinopploesn
DK162057C (da) Fremgangsmaade til fremstilling af et immunogent kompleks
NO813726L (no) Fremgangsmaate for fremstilling av piperazinyl-benzo-heterocykliske forbindelser
NO832616L (no) Fremgangsmaate for fremstilling av et dihydroerytromycin-derivat
DK350083D0 (da) Fremgangsmade til fremstilling af phenylethanolaminer
DK164383D0 (da) Fremgangsmade til fremstilling af phospholipidderivater
ES520249A0 (es) Procedimiento de producir preparaciones de insulina.
NO168745C (no) Fremgangsmaate for fremstilling av farmasoeytisk blandingspreparat
RO86511A (ro) Procedeu pentru prepararea unor beta-lactame
ES523701A0 (es) Procedimiento de preparar derivados de penicilina.
NO862587L (no) Fremgangsmaate for fremstilling av en injiserbar opploesning inneholdende et antitumorantracyklinglykosid.
DK347383D0 (da) Fremgangsmade til fremstilling af phospholipidderivater
DK299483D0 (da) Fremgangsmade til fremstilling af n-phosphonomethylglycin
DK283083A (da) Fremgangsmaade til fremstilling af n-phosphonomethylglycin
DK136481A (da) Fremgangsmaade til fremstilling af et insulinforstadium
DK451883D0 (da) Fremgangsmade til fremstilling af 4-methyl-5-alkylthiometyl-imidazoler
ES521941A0 (es) Procedimiento de preparar derivados de penicilina.
NO833655L (no) Fremgangsmaate for fremstilling av antigen
DK361983A (da) Fremgangsmaade til fremstilling af meldroejealkaloider
DK394783D0 (da) Fremgangsmade til fremstilling af n-phosphonometylglycin
NO833128L (no) Fremgangsmaate til fremstilling av substituerte 1-pyridyloxy-3-indolylalkylamino-2-propanoler
RO81640A (ro) Procedeu de preparare a insulinei
ES505516A0 (es) Procedimiento de preparacion de soluciones estables de lipo-proteinas
DK385983D0 (da) Fremgangsmade til fremstilling af 1-oxacephamer
NO832938L (no) Fremgangsmaate for fremstilling av en karsinostatisk substans

Legal Events

Date Code Title Description
MK1K Patent expired

Free format text: EXPIRED IN FEBRUARY 2003